References
World Health Organization (2016) World malaria report 2016. World Health Organization, Geneva
Jajosky RP, Jajosky AN, Jajosky PG (2017) Can exchange transfusions using red blood cells from donors with Southeast Asian ovalocytosis prevent or ameliorate cerebral malaria in patients with multi-drug resistant Plasmodium falciparum? Transfus Apher Sci 56:865
Colah R, Gorakshakar A, Nadkarni A (2010) Global burden, distribution and prevention of β-thalassemias and hemoglobin E disorders. Expert Rev Hematol 3:103–117
Sikdar M (2016) Hemoglobin E in Northeast India: a review on its origin, distribution, migration and health implication. Anthropol Rev 79:241–263
Chotivanich K, Udomsangpetch R, Pattanapanyasat K (2002) Hemoglobin E: a balanced polymorphism protective against high parasitemias and thus severe P. falciparum malaria. Blood 100:1172–1176
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
Ryan Jajosky is the CEO and part-owner of Biconcavity Inc. Philip Jajosky is CFO and part-owner of Biconcavity Inc, a biotechnology research and development company exploring drug-linked-erythrocytes. This company does not have any interest in Hemoglobin E or malaria.
Rights and permissions
About this article
Cite this article
Jajosky, R.P., Jajosky, A.N. & Jajosky, P.G. Can Exchange Transfusions Using Red Blood Cells from Donors with Hemoglobin E Trait Prevent or Ameliorate Severe Malaria in Patients with Multi-drug Resistant Plasmodium falciparum?. Indian J Hematol Blood Transfus 34, 591–592 (2018). https://doi.org/10.1007/s12288-018-0923-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12288-018-0923-3